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Abstract 
Background: Helminths infections have been suggested to worsen the outcome of HIV infection by polarizing the 
immune response towards Th2. The purpose of this study is to determine the activity of Th2 immune response by 
measuring total serum IgE level during symptomatic and asymptomatic HIV infection with and without helminths co-
infection and to define the role of deworming and/or ART on kinetics of serum IgE.
Methods: This prospective comparative study was conducted among symptomatic HIV-1 infected adults, treatment 
naïve asymptomatic HIV positive individuals and HIV negative apparently healthy controls with and without hel-
minths co-infection. Detection and quantification of helminths and determination of serum IgE level, CD4+, and CD8+ 
T cell count were done at baseline and 12 weeks after ART and/or deworming.
Results: HIV patients co-infected with helminths showed a high level of serum IgE compared to HIV patients without 
helminths co-infection (1,688 [IQR 721–2,473] versus 1,221 [IQR 618–2,289] IU/ml; P = 0.022). This difference was also 
markedly observed between symptomatic HIV infected patients after with and without helminths infection (1,690 
[IQR 1,116–2,491] versus 1,252 [703–2,251] IU/ml; P = 0.047). A significant decline in serum IgE level was observed 
12 weeks after deworming and ART of symptomatic HIV infected patients with (1,487 versus 992, P = 0.002) and with-
out (1,233 versus 976 IU/ml, P = 0.093) helminths co-infection. However, there was no significant decrease in serum 
IgE level among asymptomatic HIV infected individuals (1,183 versus 1,097 IU/ml, P = 0.13) and apparently health 
controls (666 IU/ml versus 571, P = 0.09) without helminths co-infection 12 weeks after deworming.
Conclusions: The significant decline of serum IgE level 12 weeks after deworming of both symptomatic and asymp-
tomatic patients indicate a tendency to down-regulate the Th2 immune response and is additional supportive evi-
dence that deworming positively impacts HIV/AIDS diseases progression. Thus, deworming should be integrated with 
ART program in helminths endemic areas of tropical countries.
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Background
An imbalance between a Th1 and Th2 cytokine profile 
with elevated serum immunoglobulin E (IgE) level was 
reported during acute HIV infection [1] indicating an 
abnormal T cell regulation of antibody synthesis by B 
cells. The presence of elevated IgE has been also correlated 
with disease progression and reported to signal the onset 
of opportunistic infections in patients with advanced HIV 
diseases and lowers CD4+ T cells [2, 3]. In sub-Sahara 
African countries where HIV-helminths co-infection is 
common, immune activation during HIV-helminths co-
infection is complex [4–8]. The immune response of the 
host to helminths infection correlates with the produc-
tion of interleukins (IL-4, 5, 9, 10, 13) and consequently 
the development of strong IgE response [2]. It is suggested 
that HIV- helminths co-infected individuals experience 
a marked shift from a Th1 response to a predominantly 
Th2 response [9–11]. This has been speculated to increase 
the risk of HIV transmission [10] and a cause for elevated 
plasma HIV RNA level and rapid diseases progression 
among sub Saharan Africa patients [11]. However, the 
administration of antiretroviral therapy (ART) [12, 13] 
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and treatment of helminths infestations [10] showed a 
tendency to down-regulate the observed immune activa-
tion. We and others have observed an increased serum 
IgE level among diarrheic and tuberculosis patients [14–
16] and a decline in serum IgE [14] and HIV RNA level 
[17–22] after treatment of helminths.
Despite the high rate of HIV-helminths co-infection 
and the benefit of deworming [9, 10, 14, 17–22], there is 
no routine screening for helminths infection and/or reg-
ular and/or mass deworming in most tropical countries 
including Ethiopia even for HIV/AIDS patients. There is 
little evidence regarding benefits of deworming in HIV-
infected individuals receiving ART. Accordingly, we 
hypothesise that dewoming during initiation of ART will 
significantly reverse the elevated Th2 immune response. 
To explore this hypothesis, we present here preliminary 
data on the kinetics of IgE levels in vitro as an activity of 
Th2 immune response in symptomatic and asymptomatic 
HIV infection with or without helminths co-infection.
Methods
Patients
This prospective comparative study was conducted at 
University Gondar Hospital, northwest Ethiopia among 
symptomatic HIV-1 infected adults at initiation of ART 
[with (N  =  40) and without (N  =  20) helminths co-
infection], asymptomatic HIV positive individuals [with 
(N = 20) and without (N = 25) helminths co-infection] 
and HIV negative apparently healthy controls [with 
(N = 10) and without (N = 15) helminths co-infection]. 
The cohort profile is summarized in Figure  1. Patients 
enrolment was as follows: On one hand, consecutive clin-
ically symptomatic patients with known HIV serostatus 
above 18  years of age, seeking treatment and willing to 
participate were evaluated with a standardized form at 
enrolment. On the other hand, detailed clinical history 
and complete physical examination including for any 
clinical signs as the WHO clinical staging of HIV infec-
tion were made for asymptomatic patients and enrolled 
when only if they were clinically asymptomatic and had 
no previous AIDS-defining conditions. Patients were 
excluded for the following reasons or conditions: preg-
nancy, treatment with single dose nevirapine for preven-
tion of mother-to-child transmission of HIV or any other 
antiretroviral therapy (ART), known diabetes, hyperten-
sion, epilepsy, liver, cardiac and renal diseases, genital 
ulcer or active tuberculosis or atopic diseases (allergic 
asthma, allergic rhinitis or atopic dermatitis-according to 
self-reported and physician diagnosed allergy following 
the modified version of International Study of Asthma 
and Allergies module) at enrolment.
ART eligibility was based on the previous WHO rec-
ommendation with CD4+ T cell count of less than 
200  cells/mm3 [23]. Accordingly, the 40 symptomatic 
HIV–helminths co-infected individuals started com-
bined ART (D4T  +  3TC  +  NVP; D4T  +  3TC  +  EFV; 
ZDV +  3TC +  NVP; or ZDV +  3TC +  EFV) and also 
single dose 400 mg albendazole (Group-1, n = 40). Until 
the end of the study the level of adherence was optimal. 
The 20 symptomatic HIV infected individuals without 
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Figure 1 Cohort of HIV-1 infected individuals with helmitnhs and without helminths infection included in the study. Keys: ART- Antiretroviral drugs, 
AH- Antihelminthic drug.
Page 3 of 8Mulu et al. J Transl Med  (2015) 13:236 
helminths started ART (Group-2, n  =  20). The asymp-
tomatic HIV infected individuals were classified into 2 
based on helminths infection: patients with (Group-3, 
n  =  20) and without (Group-4, n  =  25) helminths co-
infection. HIV negative apparently healthy controls were 
also grouped into two: [with (n = 10), Group 5 and with-
out (n =  15), Group-6 helminths co-infection]. Asymp-
tomatic HIV infected individuals and apparently healthy 
blood donors with helminthic infection were dewormed 
with 400 mg albendazole. Moreover, 200 mg albendazole 
twice daily for 3 consecutive days was given for those 
found to have Strongyloide stercoralis; and 40  mg/kg 
praziquantel for those found to have Schistosoma man-
soni. All subjects did not show any symptoms related to 
intestinal parasitic infection and atopic diseases (allergic 
asthma, allergic rhinitis or atopic dermatitis).
Blood collection and analysis
At enrolment and 12  weeks after albendazole treat-
ment, 5  ml venous blood was collected in vacutainer 
tubes containing EDTA. T-cells count was made using 
flow cytometer (FACSCount system; Becton–Dickin-
son, San Jose, CA, USA) following the manufacturer’s 
protocol. When clot is retracted serum was separated 
and stored at −40°C until used for investigations. The 
total serum IgE levels were quantified by the total IgE 
ELISA kit (IBL Immunobiological Laboratories, Ham-
burg, Germany) following the manufacturer’s instruc-
tions. Briefly, 10 ml serum samples or standard IgE were 
pipetted in duplicates into wells of microtiter plates 
precoated with monoclonal mouse antihuman IgE 
antibody together with per-oxidase conjugated antihu-
man IgE. After incubation for 30 min at room tempera-
ture the plates were rinsed with diluted wash buffer to 
remove unbound material. Then a substrate solution 
(tetra methyl benzidine) was pipetted and incubated 
for 15 min to induce development of colour. The reac-
tion was terminated by the addition of stop solution 
and the resulting dye was measured in a spectropho-
tometer (Anthos Labtec Instruments, Salzburg, Austria) 
at a wave length of 450 nm against the substrate blank. 
The IgE concentration of the samples was read from a 
standard curve. Subjects found positive for intestinal 
protozoa (Entamoeba histolytica and Giardia lamblia) 
and Hookworm, Taenia saginata and Hymenolopis 
nana were not included for IgE determination. This is 
because of different IgE responses observed in protozoal 
and helminths infections.
Stool examinations
Stool samples collected at enrolment and 12 weeks after 
ART and/or anti-helminthic treatment were examined 
in 30–60 min using direct microscopy and formol-ether 
sedimentation techniques. Coarse quantification of eggs 
was made using the Kato-Katz method and a quantita-
tive variable scoring (light infection/low worm burden, 
moderate infection/medium worm burden and heavy 
infection/massive worm burden) was created for each 
helminth following the standard procedure used by 
WHO [24].
Statistical analyses
The data was analyzed using to SPSS version 17 statisti-
cal packages and GraphPad Prism 5 Software. Intestinal 
parasite densities were transformed to log10 for analysis 
and geometric mean was used. Data were summarized 
as medians and interquartile range (IQR). Non-paramet-
ric tests were performed to compare median serum IgE 
values of the different groups. The Mann–Whitney test 
and the Kruskall Wallis tests were used for comparisons 
between two groups and three or more groups, respec-
tively. Spearman’s correlation was also used to check for 
correlations between parameters. P values was consid-
ered significant with <0.05.
Ethical approval
The study protocol and design including the consent pro-
cedures were approved by Ethical Review Board of the 
University of Gondar, Ethiopia (Ref No: RPO/55/291/00). 
Written (from those who can read and write) or verbal 
(from those who can’t read and write) informed consent 
from all study subjects was also obtained. The written 
informed consent and the ethical clearance letters are 
documented. However, verbal consent was not recorded. 
Patient with HIV and/or helminthiasis was managed as 
part of the routine clinical management of patients in the 
health care facilities following the national guidelines.
Results
Baseline differences in serum IgE level, CD4+ and CD8+ T 
cell counts
The distribution of intestinal parasites detected and the 
demographic characteristics and immunological indi-
ces of the study groups are summarized in Tables 1 and 
2. The mean age and male–female ratio in both groups 
was not different (Table  2). Although, it is very difficult 
to have a normal range of IgE at population level, a range 
of values of IgE levels was defined enabling the analysis 
of the frequency of normal, moderate and elevated IgE 
levels in each group of patients. Normal value (N) was 
adjusted and defined by the mean IgE levels from HIV 
negative apparently healthy helminths negative controls 
from the same geographic locale (562.5 IU/ml). Accord-
ingly, serum IgE values between N and 1.5  N (562.5–
843.75  IU/ml) were considered as low IgE levels and 
those between 1.5  N and 2  N (843.75–1,125  IU/ml) as 
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moderate IgE levels, with the highest levels being above 
2 N (>1,125 IU/ml).
As indicated in Table 2 and Figure 2, irrespective of hel-
minths infection individuals infected with HIV showed 
significantly high serum IgE level compared to HIV sero-
negative apparently healthy controls (1,439, [IQR 498–
2,771] versus 764 [IQR 134–1,683] IU/ml; P  =  0.001). 
Similarly, HIV patients co-infected with helminths showed 
a high level of serum IgE compared to HIV patients with-
out helminths co-infection (1,688 [IQR 721–2,473] versus 
1,221 [IQR 618–2,289] IU/ml; P = 0.022). This difference 
was also markedly observed between symptomatic HIV 
infected patients with and without helminths infection 
(1,690 [IQR 1,116–2,491] versus 1,252 [703–2,251 IU/ml; 
P = 0.047). There was no statistically significant difference 
on the level of serum IgE level in HIV positive individu-
als co-infected with type of helminths (P =  0.07). How-
ever, individuals co-infected with multiple helminths had 
a higher mean serum IgE level than that of those infected 
with single helminth (1,994 ± 456 versus 1,554 ± 551 IU/
ml). Among those infected with helminths irrespective of 
HIV infection, a statistically significant association was 
found between helminths egg intensity (representing “hel-
minth egg load”) in stool and their serum IgE level. The 
mean baseline serum IgE level was significantly different 
between individuals with high or moderate (n = 12) hel-
minth intensity and in individuals with low (n = 28) hel-
minth intensity (2,156 versus 1,797 IU/ml; P = 0.025). In 
all groups the levels of serum IgE were not correlated with 
age and gender differences.
At baseline there was no significant difference in CD4+ 
T cell counts between symptomatic HIV-1 infected 
patients with and without helminth co-infection (169 
[IQR 49–207] versus 166 ±  59  cells/mm3, respectively). 
However, the mean CD4+ T cell count in asympto-
matic HIV-1 positive individuals with helminths was 
lower than that of those without helminth co-infec-
tion (577 ±  128 versus 635 ± 90 cells/mm3). Moreover, 
the mean level of CD8+ T cells count was significantly 
higher in those with helminth co-infected than those 
without helminth coinfected in both symptomatic HIV 
infected patient (1,070 ± 103 versus 869 ± 87 cells/mm3, 
P  =  0.029) and asymptomatic HIV positive individu-
als (1,009 ±  82 versus 813 ±  71  cells/mm3, P =  0.014). 
A strong relationship is observed between IgE and the 
immune status as assessed by CD4 cell count of less than 
Table 1 Distribution of  intestinal parasite among  acute 
sero-converters and symptomatic HIV/AIDS patients
AL, Ascaris lumbricoides; TT, Trichuris trichiura; HW, Hookworm; SS, Strongyloide 
stercoralis; SM, Schistosoma mansoni; TS, Taenia saginata; HN, Hymenolopis nana; 
GL, Gardia lamblia; EH/D, Entaeamba histolytica/dispar.







 AL 31 16 8
 TT 11 5 3
 HW 6 4 2
 SS 3 1 0
 SM 1 1 0
 TS 3 1 1
 HN 1 0 0
Protozoans
 GL 2 0 0
 EH/D 3 0 0
Table 2 Summary of demographic characteristics and immunological indices
a Significant difference compared to asymptomatic group without helminths and symptomatic group with helminths, P < 0.05.
b Significant difference compared to asymptomatic group with helminths and symptomatic group without helminths, P < 0.01.
c Significant difference compared with asymptomatic group without helminths, P < 0.01.
d Significant difference compared to symptomatic and asymptomatic group without helminths, P < 0.01.
Characteristics Symptomatic HIV infection (N = 60) Asymptomatic HIV infection (N = 45) Healthy controls (N = 25)
Males 28 19 17
Females 32 26 8
Mean age (years) 30.6 ± 8 29.0 ± 9 26.5 ± 7
Median (IQR) total serum IgE (IU/ml)
 With helminths 1,593 (1,132–2,497)b 1,231 (706–2,241)c 908 (401–1,625)
 Without helminths 1,259 (625–2,256) 831 (628–1,617) 662 (127–875)
Median (IQR) CD4+ T cells count (cells/mm3 of blood)
 With helminths 169 (48–201) 555 (128–672)a 707 (98–1,003)
 Without helminths 161 (39–218) 677 (190–879) 792 (91–1,129)
Median (IQR) CD8+ T cells count (cells/mm3 of blood)
 With helminths 1,070 ± 103d 1,009 ± 82 1,072 ± 96
 Without helminths 869 ± 87 813 ± 71 893 ± 84
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200 or greater than 200 cells/mm3 i.e. 1,736 ± 231 versus 
1,583 ± 171 IU/ml, P = 0.013.
Impact of albendazole on serum IgE level, CD4+ and CD8 + 
T cells count
As indicated in Figure  3, a significant decline in serum 
IgE level was observed 12  weeks after deworming and 
ART of symptomatic HIV infected patients with (1,487 
versus 992, P = 0.002) and without (1,233 versus 976 IU/
ml, P =  0.093) helminths co-infection. Similarly, serum 
IgE level was significantly reduced among asympto-
matic HIV infected individuals (1,261 versus 996  IU/
ml, P  =  0.0001) and apparently health controls (993 
versus 646  IU/ml, P  =  0.0002) with helminths coinfec-
tion 12  weeks after deworming. However, there was no 
significant decrease in serum IgE level among asympto-
matic HIV infected individuals (1,183 versus 1,097  IU/
ml, P  =  0.13) and apparently health controls (666  IU/
ml versus 571, P = 0.09) without helminths co-infection 
12  weeks after deworming. After controlling ART sta-
tus and helminths coinfection a significant reduction 
in serum IgE level was observed in all groups (data not 
shown).
Patients with lower CD4+ T cell counts (<200  cells/
mm3) showed a relatively lower reduction in the total 
serum IgE as compared with patients with higher CD4+ 
T cells count (>200  cells/mm3) after 12  weeks of either 
ART or albendazole (1,436–1,231 versus 1,583–1,107 IU/
ml). Twelve weeks after albendazole treatment, a signifi-
cant reduction in CD8+ T cells and an increase in CD4+ 
T cells count were observed (P =  0.0012). There was a 
significant reduction in CD8+ T cells count in symp-
tomatic helminths co-infected patients 12  weeks after 
albendazole treatment (1,070 ±  versus 872, P =  0.039). 
On the contrary, there was an a relative higher increase 
in mean CD4+ T cell count in patients with ART and 
albendazole treatment (from 168 to 249) as compared 
with patients with only ART (from 166 to 234) though 
the difference was insignificant. The mean serum IgE 
level among asymptomatic HIV positive individuals was 
increased in 12 weeks’ time from 1,321 ± to 1,544 IU/ml 
in the absence of both ART and albendazole and was par-
allel with the decrease in CD4+ T cells count from 677 to 
596 cells/mm3.
Discussion
In this study altered immune response as measured by 
total serum IgE level among symptomatic HIV infected 
patients, asymptomatic HIV positive individuals and 
healthy controls with and without helminths co-infec-
tion and the impact of deworming and/or ART on these 
immune activation was assessed within defined groups 
of population from tropical settings of Ethiopia where 
both HIV and helminths infections are common. Con-
sistent with the earlier suggestions [25–27] that Afri-
cans generally present with elevated total serum IgE 
levels and our previous observations [14–16], patients 
in this study also showed a high total serum IgE level 
as shown by more than three-folds of the total IgE 
above the reference ranges irrespective of HIV and hel-










































Figure 2 Serum IgE levels in adult HIV patients before initiation of 
ART and albendazole. Horizontal lines are medians and IQRs (25 and 
75 centile). Horizontal lines are medians and interquartile ranges 
(IQRs) (25 and 75 centile) and the black dot represents outlier values. 
Keys: SyPH± Symptomatic HIV-1 infected patients with and without 
helminths infection, ASyPH± Asymptomatic HIV-1infected individuals 
with and without helminths infections, HCH± Healthy controls with 
















































Figure 3 Comparison of changes in median total serum IgE at base-
line (before treatment) and at 12 weeks after successful deworming 
in symptomatic, asymptomatic and health controls. Horizontal lines 
are medians and interquartile ranges (IQRs) (25 and 75 centile) and 
the black dot represents outlier values. Keys: Similar to Figure 2
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between helminth egg intensity and serum IgE level 
may partly explain the elevated total serum IgE levels 
observed in sub-Saharan regions, where heavy helmin-
thic infections are widespread [14–16, 25–27]. It could 
be also associated with race-associated genetic mecha-
nism that contributes for higher level of IgE in Blacks 
than Caucasians [28] and possibly due to the higher 
rate of malnutrition in Ethiopia [29] which in parallel 
increase in serum IgE.
We have previously shown that helminths infections 
cause immune activation by increasing memory CD4+ T 
cells which are reported to largely express CCR5 by the 
non-syncytium inducing HIV-1C subtype in Ethiopia [9]. 
The highly elevated serum IgE level in HIV patients with 
helminths co-infection in the current study might be a 
result of HIV-helminths induced immune dysregulation 
which provoke a shift in cytokine production from Th1 
to Th2 [5, 30] and the resulting polyclonal activation of 
B cells which increase secretion of IgE [31, 32]. Although 
there may be other potential factors that could contribute 
to the increase in serum IgE level, it is known that IgE 
class switching is mediated by CD4+ Th2 cells [12, 13] 
and it is unclear whether the high IgE in African popu-
lation is due to a genetic predisposition or environmen-
tal influences to mediate Th2 cell predominance [33]. 
Nevertheless, the altered of immune response during 
helimninths co-infection has been reversed to normal 
after deworming [this study, 6–8] among Ethiopians 
suggests that this decrease was indeed the result of hel-
minthic infection alone without the influence of other 
environmental factors. Thus, the role of helminths in the 
host and the other infections cannot be overemphasized 
and should therefore be adequately addressed in manag-
ing HIV-infection during helminth coinfection [18, 21, 
22, 34]. This is due to the fact that, helminths infections 
are potent stimulators of IL-4 dependent synthesis of hel-
minths specific IgE [30].
The increased serum IgE level among symptomatic 
patients irrespective of helminths co-infections and 
the high level of IgE reduction 12 weeks after ART and 
deworming when compared with that of asymptomatic 
HIV infected individuals suggest that a Th2 response has 
occurred in advanced HIV/AIDS disease conditions [27]. 
Moreover, the increased serum IgE level among asymp-
tomatic HIV positive individuals in 12 weeks time in the 
absence of both ART and albendazole is parallel with the 
decrease in CD4+ T cells count and could be associated 
with rapid diseases progression [14, 27] with time fol-
lowing the natural course of the diseases. A significant 
decline in serum IgE level 12 weeks after only deworming 
in the present study is inline with the finding that elimi-
nation or reduction of/in helminths resulted in a signifi-
cant improvement in T cell proliferation and supports 
the notion ‘deworming of helminth co-infected indi-
viduals for delaying HIV disease progression’ [9, 10, 14, 
17–22, 34]. Surprisingly, a significant decline in serum 
IgE level 12  weeks after simultaneous administration of 
ART and albendazole has been observed. This supports 
the fact that administration of ART reduces indices of 
immune activation [12, 13] and shows the presence of 
synergism between both drugs classes. However, it is dif-
ficult to ascribe the reduced IgE to only ART and alben-
dazole in view of the fact that symptomatic HIV infected 
patients were also on cotrimoxazole prophylaxis and as 
the anti-helminthic effect of cotrimoxazole cannot be 
excluded [35]. Although the CD4+ T cell counts and 
recovery rates are lower among Ethiopians than in people 
from Caucasians irrespective of the HIV infection [9, 36, 
37], an increased CD4+ T cell count and reduced CD8+ 
T cell count in HIV infected individuals with both ART 
and albendazole as compared with those from patients 
with ART was observed. The result shows the synergistic 
effects of ART and albendazole in down regulation of the 
polarized Th2 immune response.
Several studies have shown the impact of helminths 
on health, their consequences for the physical and intel-
lectual development particularly in children, and the 
long-run effects on individuals. There is also sufficient 
evidence for the benefit of deworming on achieving 
healthy physical growth, improving cognitive domains, 
and the long-run effects on individuals [38]. Similarly, 
the negative impact of helminths infection on infectious 
diseases particularly on malaria, tuberculosis and HIV 
and the role of deworming on improving the quality of 
patient life and reducing morbidity and mortality have 
been documented [38]. Nevertheless, there is no rou-
tine screening for helminths infection and/or regular or 
mass deworming in most sub-Saharan African countries 
including Ethiopia even for HIV/AIDS patients.
Limitations
This study has several limitations. First the obvious 
small sample size. Second, the short period (3 months of 
antiretroviral treatment-ART) of longitudinal observa-
tion which is relatively short to infer the mutual effect of 
ART and deworming on level of serum IgE. And, third 
the definition of allergy, which relies on self-reported and 
physician diagnosed allergy following the modified ver-
sion of International Study of Asthma and Allergies in 
Childhood module. Forth, lack of specific IgE measure-
ment before and after deworming. And lastly, although 
we and others have previously reported the association 
between eosinophil level and parasitic infection and cor-
related with higher level of total serum IgE, in this study 
we did not measure eosinophil count and could be con-
sidered as limitation of the study.
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Conclusion
The remarkably elevated IgE response in HIV patients 
irrespective of helminths co-infection suggests that HIV 
is a potent driver of IgE production like helminths. The 
significant decline of serum IgE level 12  weeks after 
administration of albendazole with and without ART 
in symptomatic patients indicate a shift in immune 
response towards Th1 which is crucial for prognosis of 
HIV patients. These are additional supportive evidence 
that deworming positively impacts HIV/AIDS diseases 
progression. Thus, mass deworming should be integrated 
with ART program in helminths endemic areas of tropi-
cal countries.
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